ADME Study of [14^C]-Ibrexafungerp in Healthy Male Subjects

NCT05668429 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Fungal Disease

Interventions

DRUG: Ibrexafungerp

Sponsor

Scynexis, Inc.